69 related articles for article (PubMed ID: 27330893)
1. Disruption of latent HIV in vivo during the clearance of actinic keratosis by ingenol mebutate.
Jiang G; Maverakis E; Cheng MY; Elsheikh MM; Deleage C; Méndez-Lagares G; Shimoda M; Yukl SA; Hartigan-O'Connor DJ; Thompson GR; Estes JD; Wong JK; Dandekar S
JCI Insight; 2019 Apr; 4(7):. PubMed ID: 30944245
[TBL] [Abstract][Full Text] [Related]
2. Management Pearls on the Treatment of Actinic Keratoses and Field Cancerization.
Piquero-Casals J; Morgado-Carrasco D; Gilaberte Y; Del Rio R; Macaya-Pascual A; Granger C; López-Estebaranz JL
Dermatol Ther (Heidelb); 2020 Oct; 10(5):903-915. PubMed ID: 32681454
[TBL] [Abstract][Full Text] [Related]
3. Cold Atmospheric Plasma (CAP) for the Treatment of Actinic Keratosis and Skin Field Cancerization: Clinical and High-Frequency Ultrasound Evaluation.
Arisi M; Soglia S; Guasco Pisani E; Venturuzzo A; Gelmetti A; Tomasi C; Zane C; Rossi M; Lorenzi L; Calzavara-Pinton P
Dermatol Ther (Heidelb); 2021 Jun; 11(3):855-866. PubMed ID: 33738749
[TBL] [Abstract][Full Text] [Related]
4. International time trends and differences in topical actinic keratosis therapy utilization.
Zhao HJ; Ushcatz I; Tadrous M; Aoki V; Chang AY; Levell NJ; Von Schuckmann L; Drucker AM
JAAD Int; 2024 Sep; 16():18-25. PubMed ID: 38764482
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of tirbanibulin 1% ointment in the treatment of cancerization field: a real-life Italian multicenter observational study of 250 patients.
Nazzaro G; Carugno A; Bortoluzzi P; Buffon S; Astrua C; Zappia E; Trovato E; Caccavale S; Pellegrino V; Paolino G; Balestri R; Lacava R; Ciccarese G; Verdelli A; Barruscotti S; Valenti M; Toni G; Giacalone S; Zavattaro E; Gironi LC; Mercuri SR; Ribero S; Gisondi P; Sena P; Marzano AV
Int J Dermatol; 2024 Apr; ():. PubMed ID: 38605473
[TBL] [Abstract][Full Text] [Related]
6. Reflectance confocal microscopy as noninvasive tool for monitoring tirbanibulin efficacy in actinic keratosis.
Venturi F; Veronesi G; Baraldi C; Dika E
Photodiagnosis Photodyn Ther; 2024 Jun; 48():104235. PubMed ID: 38851311
[TBL] [Abstract][Full Text] [Related]
7. Anti-aging Effects of Tirbanibulin 1% Ointment: A Real-Life Experience.
Li Pomi F; Peterle L; d'Aloja A; Di Tano A; Vaccaro M; Borgia F
Dermatol Ther (Heidelb); 2024 Jun; 14(6):1683-1696. PubMed ID: 38740726
[TBL] [Abstract][Full Text] [Related]
8. Ingenol mebutate-associated immune thrombocytopenic purpura.
Zuberi H; Amin SA
JAAD Case Rep; 2024 Apr; 46():30-32. PubMed ID: 38510842
[No Abstract] [Full Text] [Related]
9. Tolerability of Ingenol Mebutate Gel, 0.05%, for Treating Patients with Actinic Keratosis on the Scalp in a Community Dermatology Practice.
Bettencourt MS
J Clin Aesthet Dermatol; 2016 Mar; 9(3):20-4. PubMed ID: 27354884
[TBL] [Abstract][Full Text] [Related]
10. Clinical utility of ingenol mebutate in the management of actinic keratosis: perspectives from clinical practice.
Skroza N; Bernardini N; Proietti I; Potenza C
Ther Clin Risk Manag; 2018; 14():1879-1885. PubMed ID: 30323610
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of ingenol mebutate 0.015% gel after cryosurgery of actinic keratosis: 12-month results.
Berman B; Goldenberg G; Hanke CW; Tyring SK; Werschler WP; Knudsen KM; Larsson T; Swanson N
J Drugs Dermatol; 2014 Jun; 13(6):741-7. PubMed ID: 24918567
[TBL] [Abstract][Full Text] [Related]
12. Assessment of local skin reactions with a sequential regimen of cryosurgery followed by ingenol mebutate gel, 0.015%, in patients with actinic keratosis.
Goldenberg G; Berman B
Clin Cosmet Investig Dermatol; 2015; 8():1-8. PubMed ID: 25565875
[TBL] [Abstract][Full Text] [Related]
13. Topical Ingenol Mebutate: A New Treatment Modality for Multiple Actinic Keratoses and Field Cancerization.
Kostovic K; Gulin SJ; Mokos ZB; Ceovic R
Anticancer Agents Med Chem; 2017; 17(10):1304-1311. PubMed ID: 28270072
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic and pharmacodynamic evaluation of ingenol mebutate for the treatment of actinic keratosis.
Stockfleth E; Bastian M
Expert Opin Drug Metab Toxicol; 2018 Sep; 14(9):911-918. PubMed ID: 30074409
[TBL] [Abstract][Full Text] [Related]
15. Efficacy, safety and tolerability of field treatment of actinic keratosis with ingenol mebutate 0.015 % gel: a single center case series.
Bobyr I; Campanati A; Consales V; Giuliodori K; Scalise A; Offidani A
Springerplus; 2016; 5():627. PubMed ID: 27330893
[TBL] [Abstract][Full Text] [Related]
16. Non-invasive monitoring of subclinical and clinical actinic keratosis of face and scalp under topical treatment with ingenol mebutate gel 150 mcg/g by means of reflectance confocal microscopy and optical coherence tomography: New perspectives and comparison of diagnostic techniques.
Ruini C; Hartmann D; Bastian M; Ruzicka T; French LE; Berking C; von Braunmühl T
J Biophotonics; 2019 Jul; 12(7):e201800391. PubMed ID: 30653833
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
